Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional bevacizumab before surgery for primary pterygium
IRCT20230111057106N2Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab in pterygium, sponsored by Guilan University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
bevacizumab
03
Conditions
pterygium
Beyond the preview
Go deeper on IRCT20230111057106N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230111057106N2.